Cruzar Medsystems raised $2.9 million in a new round of equity financing, according to an SEC filing posted this week. Braintree, Mass.-based Cruzar Medsystems is developing the Houdini peripheral chronic total occlussion device. Money in the round came from 5 anonymous sources, and the company has not yet said how it plans to use funds […]
Cruzar Medsystems
Pavmed scales back IPO to $6m
Pavmed last week dramatically trimmed its pending initial public offering, saying it plans to float 1.2 million shares at $5 apiece for gross proceeds of $6 million. That’s a far cry from the $23 million top end Pavmed listed when it registered the IPO last May. Pavmed is developing devices in 5 areas, according to its […]
BSX aims for double-digit earnings growth | Medtech Wall Street news for the week of May 4, 2015
Pavmed files for $23m IPO
The entrepreneurs behind a quartet of medical device companies is betting their formula can cut down on the time and cost of getting medtech to market with a $23 million initial public offering.
